MX9301879A - MEDICATION FOR THE TREATMENT OF INFLAMMATION OF THE RESPIRATORY TRACT - Google Patents

MEDICATION FOR THE TREATMENT OF INFLAMMATION OF THE RESPIRATORY TRACT

Info

Publication number
MX9301879A
MX9301879A MX9301879A MX9301879A MX9301879A MX 9301879 A MX9301879 A MX 9301879A MX 9301879 A MX9301879 A MX 9301879A MX 9301879 A MX9301879 A MX 9301879A MX 9301879 A MX9301879 A MX 9301879A
Authority
MX
Mexico
Prior art keywords
respiratory tract
inflammation
treatment
medication
medicament
Prior art date
Application number
MX9301879A
Other languages
Spanish (es)
Inventor
Barbara Anne Spicer
Stephen Gerard Taylor
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MX9301879A publication Critical patent/MX9301879A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Esta invención se relaciona con el uso novedoso, en particular un uso para a manufactura de un medicamento para el tratamiento de la inflamación de las vías respiratorias y, en particular la hipersensibilidad de las vías respiratorias.This invention relates to the novel use, in particular a use for the manufacture of a medicament for the treatment of inflammation of the respiratory tract, and in particular hypersensitivity of the respiratory tract.

MX9301879A 1992-04-02 1993-04-01 MEDICATION FOR THE TREATMENT OF INFLAMMATION OF THE RESPIRATORY TRACT MX9301879A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929207400A GB9207400D0 (en) 1992-04-02 1992-04-02 Novel use

Publications (1)

Publication Number Publication Date
MX9301879A true MX9301879A (en) 1993-12-01

Family

ID=10713459

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9301879A MX9301879A (en) 1992-04-02 1993-04-01 MEDICATION FOR THE TREATMENT OF INFLAMMATION OF THE RESPIRATORY TRACT

Country Status (11)

Country Link
EP (1) EP0633778A1 (en)
JP (1) JPH07505381A (en)
KR (1) KR950700737A (en)
AU (1) AU3765193A (en)
CA (1) CA2133470A1 (en)
GB (1) GB9207400D0 (en)
HU (1) HUT75702A (en)
IL (1) IL105233A0 (en)
MX (1) MX9301879A (en)
WO (1) WO1993019755A1 (en)
ZA (1) ZA932303B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE44995A1 (en) * 1994-01-27 1995-12-18 Schering Corp MOMETASONE FUROATE FOR THE TREATMENT OF LUNG DISEASES AND RESPIRATORY TRACT
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
WO2004052863A1 (en) * 2002-12-06 2004-06-24 Kyowa Hakko Kogyo Co., Ltd. Anti-inflammatory agent
CA2541014A1 (en) 2003-10-01 2005-04-14 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
US7598261B2 (en) 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
WO2015157262A1 (en) 2014-04-07 2015-10-15 Women & Infants Hospital Of Rhode Island Novel 7-Dehydrocholesterol Derivatives and Methods Using Same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI90343C (en) * 1987-06-23 1994-01-25 Merck Patent Gmbh Process for the preparation of antihypertensive and antiarrhythmic trans-2,2-dimethylchroman-3-parent derivatives
IL88035A0 (en) * 1987-10-27 1989-06-30 American Home Prod Benzopyran derivatives,their preparation and pharmaceutical compositions containing them
ATE120459T1 (en) * 1988-12-13 1995-04-15 Beecham Group Plc BENZOPYRANE AND RELATED COMPOUNDS.
GB2242628A (en) * 1990-04-06 1991-10-09 Sandoz Ltd Asthma prophylactic use of K+ channel activators

Also Published As

Publication number Publication date
AU3765193A (en) 1993-11-08
GB9207400D0 (en) 1992-05-13
EP0633778A1 (en) 1995-01-18
HUT75702A (en) 1997-05-28
JPH07505381A (en) 1995-06-15
HU9402816D0 (en) 1994-12-28
WO1993019755A1 (en) 1993-10-14
KR950700737A (en) 1995-02-20
CA2133470A1 (en) 1993-10-14
ZA932303B (en) 1994-06-06
IL105233A0 (en) 1993-07-08

Similar Documents

Publication Publication Date Title
ES2177780T3 (en) MEDICATIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES USING INTERFERON TAU.
ATE515265T1 (en) VITAMIN D AND ITS ANALOGUES FOR THE TREATMENT OF TUMORS AND OTHER HYPERPROLIFERATIVE DISEASES
ES2164097T3 (en) USE OF TOPIC ANESTHETICS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF BRONCHIAL ASTHMA.
DE59108854D1 (en) MEDICINAL PRODUCTS, THEIR PRODUCTION AND THEIR USE IN THE CONTROL OF PAIN AND / OR INFLAMMATION OF ANIMALS AND HUMANS
BR1100860A (en) Compound, anti-inflammatory drug, pharmaceutical composition, epimer r and epimer s of the compound
IS3959A (en) Method of preparation of a composition comprising a medicament which is a bronchodilator and anti-inflammatory drug for the treatment and use of respiratory disorders
IT1254517B (en) 14-BETA IDROSSI-10-DEACETIL-BACCATINA III, ITS DERIVATIVES, THEIR PREPATION AND THERAPEUTIC USE
DE69129248D1 (en) Peptides with endothelin antagonistic activity, their preparation and pharmaceutical compositions
AR002261A1 (en) POWDER COMPOSITION FOR THE ADMINISTRATION OF INHALATION OF USEFUL POLYPEPTIDES IN MEDICINE, METHODS FOR THE MANUFACTURE OF SUCH COMPOSITION, AND USE OF THE COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DISEASES THROUGH THE TRACT TRACT.
ATE82121T1 (en) MEDICATIONS FOR THE THERAPEUTIC TREATMENT OF ALOPECIA.
NO20101190L (en) Use of buprenorphine in the manufacture of a medicament
DE69713151D1 (en) CYCLOSPORINE DERIVATIVE, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION
AR003984A1 (en) ANTIPRURITICAL, COSMETIC AND / OR PHARMACEUTICAL COMPOSITIONS, PROCEDURE FOR ITS PREPARATION AND USE OF SUCH COMPOSITIONS TO OBTAIN A MEDICATION.
EP0382066A3 (en) Use of dihydroliponic acid as an analgetic, antiphlogistic and/or cytoprotective agent
ITRM920270A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF SKIN AND ORAL MUCOSA INFLAMMATION.
ES2181165T3 (en) USE OF A PEPTIDE ASSOCIATED WITH LATENCY FOR THE PREPARATION OF A MEDICINAL PRODUCT TO INCREASE WOUND HEALING.
ES2061989T3 (en) USE OF ALKYL ESTERS OF PYROGLUTAMIC ACID FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ICTIOSIS.
BR9709838A (en) Administration regimen that provides a blood plasma profile of an h +, k + -atpase inhibitor oral pharmaceutical composition and the use of h +, k + -atpase inhibitor and processes to improve the inhibition of gastric acid secretion and the therapeutic effect on treatment of gastrointestinal disorders and to receive an extended plasma profile of an h +, k + -atpase inhibitor
ES2130152T3 (en) MEDICINES TO TREAT INFLAMMATORY PAIN OR ANALGESIA CONTAINING A NSAID AND RANITIDINE / BISMUTE CITRATE.
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
ES2147788T3 (en) 3,4-DIARILCROMANOS FOR THE TREATMENT OF DERMATITIS.
ES2111163T3 (en) USE OF PHOSPHONATES FOR THE TREATMENT OF OSTEOPOROSIS.
MX9301879A (en) MEDICATION FOR THE TREATMENT OF INFLAMMATION OF THE RESPIRATORY TRACT
ITRM910002A0 (en) USE OF ACETYL L-CARNITINE IN THE THERAPEUTIC TREATMENT OF COMA AND PHARMACEUTICAL COMPOSITIONS USEFUL IN SUCH TREATMENT.
ES2089286T3 (en) NEW 2-AMINO-5-CIANO-1,4-DIHIDROPIRIDINAS, PROCEDURE FOR ITS PREPARATION AND USE IN MEDICINES.